Biotechnology
Swiss companies operating in the same biotechnology industry
The list below has Swiss companies that operate under the same industry, biotechnology. The list helps track their performance, income statement, and more. Sorted by any necessary metric, it can show the most expensive stocks of the industry such as LONZA GROUP AG or those with the best price dynamics like XBIOTECH INC, thus assisting in designing strategies of any focus.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 GISGILEAD SCIENCES | 104.906 B CHF | 84.244 CHF | +12.55% | 230 | 2.34 | 1,184.88 | 0.07 CHF | −98.33% | 3.17% | Health technology | Buy |
 LO3LONZA GROUP AG | 39.565 B CHF | 551.528 CHF | +0.50% | 43 | 0.24 | 67.80 | 8.14 CHF | −80.56% | 0.73% | Health technology | Buy |
| LONNLONZA N | 39.565 B CHF | 549.2 CHF | +0.26% | 122.967 K | 1.01 | 67.51 | 8.14 CHF | −80.56% | 0.73% | Health technology | Buy |
| LONNELONZA N 2. LINIE | 39.565 B CHF | 550.0 CHF | −0.07% | 3.7 K | 1.00 | 67.61 | 8.14 CHF | −80.56% | 0.73% | Health technology | — |
 22UABIONTECH SEDR | 22.951 B CHF | 96.124 CHF | +1.07% | 5 | 0.15 | — | −1.83 CHF | −117.32% | 0.00% | Health technology | Buy |
 0QFMODERNA INC | 15.725 B CHF | 43.039 CHF | −5.05% | 117 | 2.42 | — | −4.94 CHF | +42.26% | 0.00% | Health technology | Neutral |
 1CGCRISPR THERAPEUTIC | 3.845 B CHF | 43.991 CHF | +4.65% | 100 | 1.11 | — | −2.39 CHF | +41.68% | 0.00% | Health technology | Buy |
 NVV1NOVAVAX INC | 1.245 B CHF | 7.521 CHF | −16.24% | 1.6 K | 3.40 | — | −2.49 CHF | +61.78% | 0.00% | Health technology | Neutral |
 8H0POLYPEPTIDE GROUP | 1.021 B CHF | 32.113 CHF | +13.52% | 40 | 0.38 | — | −0.83 CHF | −179.07% | 0.00% | Health technology | Neutral |
| PPGNPOLYPEPTIDE N | 1.021 B CHF | 30.90 CHF | −2.37% | 17.302 K | 0.97 | — | −0.83 CHF | −179.07% | 0.00% | Health technology | Neutral |
 KURNKUROS N | 992.06 M CHF | 27.80 CHF | −2.11% | 151.503 K | 0.76 | — | −0.24 CHF | +28.58% | 0.00% | Health technology | Strong buy |
| YTSNKUROS BIOSCIENCES | 992.06 M CHF | 28.168 CHF | +2.51% | 400 | 1.21 | — | −0.24 CHF | +28.58% | 0.00% | Health technology | Strong buy |
 6MLMOLECULAR PARTNERS | 222.804 M CHF | 4.979 CHF | −16.22% | 400 | 1.22 | — | −1.90 CHF | −6.91% | 0.00% | Health technology | Buy |
| MOLNMOLECULAR PARTNERS N | 222.804 M CHF | 5.52 CHF | +6.15% | 22.724 K | 0.72 | — | −1.90 CHF | −6.91% | 0.00% | Health technology | Buy |
 4XBXBIOTECH INC | 200.695 M CHF | 7.031 CHF | +18.29% | 50 | 0.08 | — | −1.03 CHF | −23.64% | 0.00% | Health technology | — |
 1S9SERES THERAPEUTICS | 106.219 M CHF | 0.630 CHF | −17.00% | 2 K | 0.56 | — | −1.06 CHF | +4.63% | 0.00% | Health technology | Buy |
 AFMDAFFIMED N V | 51.157 M CHF | 3.150 CHF | — | 1.297 K | — | — | −2.50 CHF | −254.59% | 0.00% | Health technology | Strong buy |